Literature DB >> 12711393

Comparison of the sequences of Turbo and Sulculus indoleamine dioxygenase-like myoglobin genes.

Tomohiko Suzuki1, Kouhei Yokouchi, Hozumi Kawamichi, Yasufumi Yamamoto, Kouji Uda, Hajime J Yuasa.   

Abstract

Some archaeogastropodic molluscs, including Sulculus and Turbo, contain an unusual approximately 40 kDa myoglobin in their buccal masses. This myoglobin can bind oxygen reversibly, but has a lower oxygen affinity than vertebrate and invertebrate myoglobins. Amino acid sequences clearly show that Sulculus and Turbo myoglobins evolved not from the globin gene but from the gene for indoleamine dioxygenase (IDO), a tryptophan-degrading enzyme. The Turbo myoglobin gene has been determined to consist of 14 exons and 13 introns. Compared with the known Sulculus IDO-like myoglobin gene, all splice junctions except two are conserved exactly between the two genes. The exon/intron organization of these myoglobin genes is also highly homologous with human IDO (ten exon/nine intron structure); splice junctions of six introns were exactly conserved among the three genes, suggesting that these introns have been conserved for at least 600 million years. To look for putative IDO genes in Turbo or Sulculus, we re-examined the genomic DNA fragments amplified by PCR in full detail, and found intron 2 in two distinct Sulculus fragments (A and B). Fragment A with a 576 bp intron corresponded exactly to the myoglobin gene of Sulculus. On the other hand, fragment B, containing a 239 bp intron, differed significantly from fragment A in nucleotide and translated amino acid sequences. Detailed sequence comparison suggests that fragment B may be derived from a putative IDO gene of Sulculus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711393     DOI: 10.1016/s0378-1119(03)00467-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  NADH oxidase activity of indoleamine 2,3-dioxygenase.

Authors:  Federico I Rosell; Hsin H Kuo; A Grant Mauk
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

Review 2.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

3.  Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.

Authors:  Hajime J Yuasa; Helen J Ball
Journal:  J Mol Evol       Date:  2010-12-18       Impact factor: 2.395

4.  The Sorcerer II Global Ocean Sampling expedition: expanding the universe of protein families.

Authors:  Shibu Yooseph; Granger Sutton; Douglas B Rusch; Aaron L Halpern; Shannon J Williamson; Karin Remington; Jonathan A Eisen; Karla B Heidelberg; Gerard Manning; Weizhong Li; Lukasz Jaroszewski; Piotr Cieplak; Christopher S Miller; Huiying Li; Susan T Mashiyama; Marcin P Joachimiak; Christopher van Belle; John-Marc Chandonia; David A Soergel; Yufeng Zhai; Kannan Natarajan; Shaun Lee; Benjamin J Raphael; Vineet Bafna; Robert Friedman; Steven E Brenner; Adam Godzik; David Eisenberg; Jack E Dixon; Susan S Taylor; Robert L Strausberg; Marvin Frazier; J Craig Venter
Journal:  PLoS Biol       Date:  2007-03       Impact factor: 8.029

Review 5.  Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.

Authors:  Burles A Johnson; Babak Baban; Andrew L Mellor
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

6.  Development-specific differences in the proteomics of Angiostrongylus cantonensis.

Authors:  Hui-Cong Huang; Li-Li Yao; Zeng-Mei Song; Xing-Pan Li; Qian-Qian Hua; Qiang Li; Chang-Wang Pan; Chao-Ming Xia
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

7.  Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.

Authors:  Micah T Nelp; Patrick A Kates; John T Hunt; John A Newitt; Aaron Balog; Derrick Maley; Xiao Zhu; Lynn Abell; Alban Allentoff; Robert Borzilleri; Hal A Lewis; Zeyu Lin; Steven P Seitz; Chunhong Yan; John T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.